DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

GLORY-1

Mazdutide

China · without diabetes · 32 weeks · n=610

Double-blind, placebo-controlled. Treatment-policy estimand.

Mean body weight change at 32 weeks
  • Mazdutide 4 mg−10.09%
  • Mazdutide 6 mg−12.55%
  • Placebo+0.45%

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.